Patents Assigned to ViaLase, Inc.
  • Patent number: 12002567
    Abstract: A look-up table for use in determining an energy parameter for photodisrupting ocular tissue with a laser is generated by determining a plurality of individual spot size distributions, wherein each of the plurality of individual spot size distributions is based on a different set of simulated data and includes an expected spot size of a laser focus at each of a plurality of locations within a modeled target volume of ocular tissue. The plurality of individual spot size distributions are combined to obtain a final spot size distribution that includes a final expected spot size of the laser focus at the plurality of locations of the focus within the modeled target volume of ocular tissue. An energy value is assigned to the plurality of locations of the focus within the modeled target volume of ocular tissue based on the final expected spot size at that location.
    Type: Grant
    Filed: November 29, 2021
    Date of Patent: June 4, 2024
    Assignee: ViaLase, Inc.
    Inventors: Guy Holland, Tibor Juhasz, Wesley W. Lummis, Eric R. Mikula, Ferenc Raksi, Manu Sharma, Hadi Srass, Carlos G. Suarez
  • Patent number: 11986424
    Abstract: A method of imaging and treating ocular tissue of an eye having a cornea, an iris, an anterior chamber, an irido-corneal angle, and a direction of view includes establishing a common optical path through the cornea and the anterior chamber into the irido-corneal angle for each of an optical coherence tomography (OCT) beam and a laser beam, where the common optical path is offset from an optical axis within the direction of view. The method also includes obtaining a circumferential OCT image of the irido-corneal angle, obtaining an azimuthal OCT image of the irido-corneal angle, and determining a treatment pattern for a volume of ocular tissue of the irido-corneal angle based on the circumferential OCT image and the azimuthal OCT image. The method further includes delivering optical energy through the laser beam in accordance with the treatment pattern.
    Type: Grant
    Filed: July 30, 2020
    Date of Patent: May 21, 2024
    Assignee: ViaLase, Inc.
    Inventors: Guy Holland, Tibor Juhasz, Wesley W. Lummis, Eric R. Mikula, Ferenc Raksi, Manu Sharma, Hadi Srass, Carlos G. Suarez
  • Patent number: 11969211
    Abstract: A device for visualizing an irido-corneal angle of an eye through a window of a patient interface configured to be placed on the eye includes and optics structure and at least one imaging apparatus. The optics structure is configured to engage with the patient interface to provide a line of sight through the window in the direction of the irido-corneal angle, and to subsequently disengage from the patient interface. The imaging apparatus is associated with the optics structure and aligned with the line of sight to enable capturing an image of the eye including the irido-corneal angle.
    Type: Grant
    Filed: November 21, 2022
    Date of Patent: April 30, 2024
    Assignee: ViaLase, Inc.
    Inventors: Scott A. Delong, Guy Holland, Tibor Juhasz, Wesley W. Lummis, Eric R. Mikula, Attila Raksi, Ferenc Raksi, Manu Sharma, Hadi Srass, Carlos G. Suarez, Joselito T. Tambo
  • Patent number: 11666483
    Abstract: A first optical subsystem includes a window with a refractive index nw and an exit lens having a refractive index nx. The exit lens is configured to couple to the window to define a first optical axis extending through the window and the exit lens. A second optical subsystem is configured to output a light beam. The light beam is directed to be incident at a convex surface of the exit lens along a second optical axis at an angle ? that is offset from the first optical axis. The window is configured to detachably couple to the cornea of the eye such that the first optical axis is generally aligned with a direction of view of the eye. The respective refractive indices nw and nx are configured to direct the light beam incident at the convex surface of the exit lens through the cornea of the eye toward the irido-corneal angle.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: June 6, 2023
    Assignee: ViaLase, Inc.
    Inventor: Ferenc Raksi
  • Patent number: 11654053
    Abstract: An initial treatment pattern defining an initial volume of ocular tissue to be modified for treating glaucoma is designed. An initial laser treatment is delivered by scanning a laser beam across ocular tissue at an initial placement in the eye in accordance with the initial treatment pattern to thereby photo disrupt the initial volume of ocular tissue. A postoperative measure of intraocular pressure (IOP) is evaluated relative to an IOP criterion to determine if the treatment was successful. If the treatment was not successful, meaning the IOP criterion was not satisfied, then a subsequent treatment pattern that defines a subsequent volume of ocular tissue to be modified, and/or a subsequent placement in the eye is determined. A subsequent laser treatment is delivered by scanning a laser beam across ocular tissue at the subsequent placement within the eye in accordance with the subsequent treatment pattern to thereby photo disrupt the subsequent volume of ocular tissue.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: May 23, 2023
    Assignee: ViaLase, Inc.
    Inventor: Ferenc Raksi
  • Patent number: 11612315
    Abstract: A device for visualizing an irido-corneal angle of an eye through a window of a patient interface configured to be placed on the eye includes and optics structure and at least one imaging apparatus. The optics structure is configured to engage with the patient interface to provide a line of sight through the window in the direction of the irido-corneal angle, and to subsequently disengage from the patient interface. The imaging apparatus is associated with the optics structure and aligned with the line of sight to enable capturing an image of the eye including the irido-corneal angle.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: March 28, 2023
    Assignee: ViaLase, Inc.
    Inventors: Scott A. Delong, Guy Holland, Tibor Juhasz, Wesley W. Lummis, Eric R. Mikula, Attila Raksi, Ferenc Raksi, Manu Sharma, Hadi Srass, Carlos G. Suarez, Joselito T. Tambo
  • Patent number: 11583445
    Abstract: Intraocular pressure in an eye is reduced by delivering a high resolution optical coherence tomography (OCT) beam and a high resolution laser beam through the cornea, and the anterior chamber into the irido-corneal angle along an angled beam path. The OCT beam provides OCT imaging for surgery planning and monitoring, while the laser beam is configured to modify tissue or affect ocular fluid by photo-disruptive interaction. In one implementation, a volume of ocular tissue within an outflow pathway in the irido-corneal angle is modified to create a channel opening in one or more layers of the trabecular meshwork. In another implementation, a volume of fluid in the Schlemm's canal is affected by the laser to bring about a pneumatic expansion of the canal. In either implementation, resistance to aqueous flow through the eye is reduced.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: February 21, 2023
    Assignee: ViaLase, Inc.
    Inventor: Ferenc Raksi
  • Patent number: 11564567
    Abstract: A target surface in an eye is located using a dual aiming beam apparatus that transmits a first aiming beam of light and a second aiming beam of light. An optics subsystem receives a laser beam from a laser source, the first aiming beam of light, and the second aiming beam of light, and directs the beams of light to be incident with the target surface and aligns the beams of light such that they intersect at a point corresponding to a focus of the laser beam. An imaging apparatus captures an image of the target surface including a first spot corresponding to the first aiming beam of light and a second spot corresponding to a second aiming beam of light. A separation between the spots indicates that the focus is away from the target surface, while overlapping spots indicate the focus is at or on the target surface.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: January 31, 2023
    Assignee: ViaLase, Inc.
    Inventors: Tibor Juhasz, Ferenc Raksi, Manu Sharma, Hadi Srass, Carlos G. Suarez, Guy Holland, Wesley W. Lummis, Eric R. Mikula, Virginia Lin
  • Patent number: 11246754
    Abstract: A target volume of ocular tissue is treated with a laser having a direction of propagation toward the target volume, where the target volume is characterized by a distal extent, a proximal extent, and a lateral extent. A layer of tissue at an initial depth corresponding to the distal extent of the target volume is initially photodisrupted using a femtosecond laser by scanning the laser in multiple directions defining an initial treatment plane. Tissue at one or more subsequent depths between the distal extent of the target volume and the proximal extent of the target volume is subsequently photodisrupted using a femtosecond laser by moving a focus of the laser in a direction opposite the direction of propagation of the laser and then scanning the laser in multiple directions defining an subsequent treatment plane. Photodisruption is repeated at different subsequent depths until tissue at the proximal extent of the target volume is photodisrupted.
    Type: Grant
    Filed: November 5, 2019
    Date of Patent: February 15, 2022
    Assignee: VIALASE, INC.
    Inventors: Guy Holland, Tibor Juhasz, Wesley W. Lummis, Eric R. Mikula, Ferenc Raksi, Manu Sharma, Carlos G. Suarez
  • Patent number: 11173067
    Abstract: An initial treatment pattern defining an initial volume of ocular tissue to be modified for treating glaucoma is designed. An initial laser treatment is delivered by scanning a laser beam across ocular tissue at an initial placement in the eye in accordance with the initial treatment pattern to thereby photo disrupt the initial volume of ocular tissue. A postoperative measure of intraocular pressure (IOP) is evaluated relative to an IOP criterion to determine if the treatment was successful. If the treatment was not successful, meaning the IOP criterion was not satisfied, then a subsequent treatment pattern that defines a subsequent volume of ocular tissue to be modified, and/or a subsequent placement in the eye is determined. A subsequent laser treatment is delivered by scanning a laser beam across ocular tissue at the subsequent placement within the eye in accordance with the subsequent treatment pattern to thereby photo disrupt the subsequent volume of ocular tissue.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: November 16, 2021
    Assignee: ViaLase, Inc.
    Inventor: Ferenc Raksi
  • Patent number: 11110006
    Abstract: Intraocular pressure in an eye is reduced by delivering a high resolution optical coherence tomography (OCT) beam and a high resolution laser beam through the cornea, and the anterior chamber into the irido-corneal angle along an angled beam path. The OCT beam provides OCT imaging for surgery planning and monitoring, while the laser beam is configured to modify tissue or affect ocular fluid by photo-disruptive interaction. In one implementation, a volume of ocular tissue within an outflow pathway in the irido-corneal angle is modified to create a channel opening in one or more layers of the trabecular meshwork. In another implementation, a volume of fluid in the Schlemm's canal is affected by the laser to bring about a pneumatic expansion of the canal. In either implementation, resistance to aqueous flow through the eye is reduced.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: September 7, 2021
    Assignee: ViaLase, Inc.
    Inventor: Ferenc Raksi
  • Patent number: 10821024
    Abstract: A first optical subsystem includes a window with a refractive index nw and an exit lens having a refractive index nx. The exit lens is configured to couple to the window to define a first optical axis extending through the window and the exit lens. A second optical subsystem is configured to output a light beam. The light beam is directed to be incident at a convex surface of the exit lens along a second optical axis at an angle ? that is offset from the first optical axis. The window is configured to detachably couple to the cornea of the eye such that the first optical axis is generally aligned with a direction of view of the eye. The respective refractive indices nw and nx are configured to direct the light beam incident at the convex surface of the exit lens through the cornea of the eye toward the irido-corneal angle.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: November 3, 2020
    Assignee: ViaLase, Inc.
    Inventor: Ferenc Raksi
  • Patent number: 10821023
    Abstract: Intraocular pressure in an eye is reduced by delivering each of a high resolution optical coherence tomography (OCT) beam and a high resolution laser beam through the cornea, and the anterior chamber into the irido-corneal angle along an angled beam path. The OCT beam provides OCT imaging for diagnostic purposes and surgery planning and monitoring, while the laser beam is configured to modify tissue. A volume of ocular tissue within an outflow pathway in the irido-corneal angle is modified to reduce a pathway resistance present in one or more of the trabecular meshwork, the Schlemm's canal, and the one or more collector channels by applying the laser beam to ocular tissue defining the volume to thereby cause photo-disruptive interaction with the ocular tissue to reduce the pathway resistance or create a new outflow pathway.
    Type: Grant
    Filed: July 16, 2018
    Date of Patent: November 3, 2020
    Assignee: ViaLase, Inc.
    Inventor: Ferenc Raksi